Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Majlinda Tafa

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Urologic Oncology|February 18, 2025
Functional, oncological, regret and complications following partial gland cryo-ablation for low-risk prostate cancer associated with MPMRI targetsHerbert Lepor, Thomas Cao, Majlinda Tafa, et al.
Urology|October 24, 2024
Five-year Oncologic Outcomes Following Primary Partial Gland Cryo-ablation Prospective Cohort Study of Men With Intermediate-risk Prostate CancerHerbert Lepor, Eli Rapoport, Majlinda Tafa, et al.
BJUI Compass|December 12, 2025
MRI performance to identify clinically significant prostate cancer following focal cryo-ablationHerbert Lepor, Samuel Parry, Majlinda Tafa, et al.
Urology|June 2, 2026
Focal Cryo-ablation for Treatment of Intermediate Favorable Risk (Grade Group 2) Prostate CancerHerbert Lepor, Jared Fiske, Majlinda Tafa, et al.
BJU International|May 14, 2025
Routine prostate biopsies not needed after cryotherapy if surveillance MRI is normalHerbert Lepor, Jesse Persily, Samuel Parry, et al.
The Canadian Journal of Urology|October 27, 2024
Implications of MRI contrast enhancement following focal prostate cancer cryoablationJames Wysock, Jesse Persily, Angela Tong, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Urologic Oncology|February 18, 2025
Functional, oncological, regret and complications following partial gland cryo-ablation for low-risk prostate cancer associated with MPMRI targetsHerbert Lepor, Thomas Cao, Majlinda Tafa, et al.
Urology|October 24, 2024
Five-year Oncologic Outcomes Following Primary Partial Gland Cryo-ablation Prospective Cohort Study of Men With Intermediate-risk Prostate CancerHerbert Lepor, Eli Rapoport, Majlinda Tafa, et al.
BJUI Compass|December 12, 2025
MRI performance to identify clinically significant prostate cancer following focal cryo-ablationHerbert Lepor, Samuel Parry, Majlinda Tafa, et al.
Urology|June 2, 2026
Focal Cryo-ablation for Treatment of Intermediate Favorable Risk (Grade Group 2) Prostate CancerHerbert Lepor, Jared Fiske, Majlinda Tafa, et al.
BJU International|May 14, 2025
Routine prostate biopsies not needed after cryotherapy if surveillance MRI is normalHerbert Lepor, Jesse Persily, Samuel Parry, et al.
The Canadian Journal of Urology|October 27, 2024
Implications of MRI contrast enhancement following focal prostate cancer cryoablationJames Wysock, Jesse Persily, Angela Tong, et al.
Pageof 1